Asian Biomedicine

Asian Biomedicine: Research, Reviews and News (ISSN 1905-7415 print; 1875-855X online) is published in one volume (of 6 bimonthly issues) a year since 2007. Asian Biomedicine (U.S. National Library of Medicine and ISO title abbreviation: Asian Biomed (Res Rev News)) is an international peer-reviewed journal covered by Clarivate Science Citation Index Expanded, Web of Science Core Collection (formerly the Institute for Scientific Information (ISI) Web of Knowledge), InCites Journal Citation Reports (Clarivate Analytics; originally ISI, previously Thomson Reuters), and is supported by the Commission on Higher Education, Ministry of Education, Thailand, with editorial offices at the Faculty of Medicine, Chulalongkorn University, Bangkok. It is intended to serve the biomedical and health sciences community of the entire Asian region and is published in cooperation with Sciendo (www.sciendo.com) a De Gruyter company (www.degruyter.com) devoted to academic publication and services, with offices at De Gruyter Poland Sp. in Warsaw.

The content of the journal is open to full access by all online without charge. No submission, or article processing or page charges (APCs) are levied on authors or their institutions. Asian Biomedicine will bear the cost of publication of articles, but will publish color Figures at its discretion.

Asian Biomedicine is an international, general medical and biomedical journal that aims to publish original peer-reviewed contributions dealing with various topics in the biomedical and health sciences from basic experimental to clinical aspects. The work and authorship must be strongly affiliated with a country in Asia, or with specific importance and relevance to the Asian region. The Journal will publish reviews, original experimental studies, observational studies, technical and clinical (case) reports, practice guidelines, historical perspectives of Asian biomedicine, clinicopathological conferences, and commentaries

Asian Biomedicine is intended for a broad and international audience, primarily those in the health professions including researchers, physician practitioners, basic medical scientists, dentists, educators, administrators, those in the assistive professions, such as nurses, and the many types of allied health professionals in research and health care delivery systems including those in training.

Rejection Rate

• 75%